Oseltamivir is an antiviral drug used to treat or prevent influenza virus type A and B. Oseltamivir was invented by Gilead Sciences, and Roche purchased the rights to develop and market Oseltamivir under the trade name TAMIFLU. Oseltamivir was launched in China in 2002. Currently, besides Roche and its subsidiary corporation, another main manufacturer in the Chinese market is Yichang HEC Changjiang Pharmaceutical.
According to CRI's market research, the sales value of Oseltamivir in the Chinese market has been increasing since 2016. The growth rate in 2019 reached 97%, which is the highest among those years. The main reason is that the number of reported influenza cases that year increased by 350% compared with it in 2018. In 2020, the sales value of Oseltamivir in China was approximately CNY351 million, which is dropped by nearly 60% Year on Year. The sharp decrease is because the home quarantine during the COVID-19 epidemic reduced the number of influenza cases. The CAGR of sales values of Oseltamivir in China is 14.8% in 2016 to 2020.
CRI analyzes that the sales of Oseltamivir will increase from 2021 to 2025 due to the increased likelihood of influenza virus infection in the future.
Topics Covered:
-The impact of COVID-19 on China's Oseltamivir market
- Sales value and volume of China's Oseltamivir 2016-2020
- Competitive landscape of China's Oseltamivir market
- Prices of Oseltamivir in China
- Prices of Oseltamivir in China by regions and manufacturers
- Analysis on factors affecting the development of China's Oseltamivir market
- Prospect of China's Oseltamivir market from 2021 to 2025
'
Table of Contents
1 Relevant Concepts of Oseltamivir
1.1 Indications for Oseltamivir
1.2 Development of Oseltamivir in China
1.3 Governmental Approval of Oseltamivir in China
1.4 The Impact of COVID-19 on Oseltamivir sales in China
2 Sales of Oseltamivir in China, 2016-2020
2.1 Sales Value of Oseltamivir
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Oseltamivir
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Oseltamivir by Dosage Form in China, 2016-2020
2.3.1 Granule
2.3.2 Capsule
3 Analysis of Major Oseltamivir Manufacturers in China, 2016-2020
3.1 Analysis of Market Share of Major Oseltamivir Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Yichang HEC Changjiang Pharmaceutical Co., Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of Kewei (Yichang HEC's Oseltamivir) in China
3.3 Shanghai Roche Pharmaceuticals Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of TAMIFLU (Shanghai Roche's Oseltamivir) in China
3.4 Roche Pharma (Schweiz) AG
3.4.1 Enterprise Profile
3.4.2 Sales of TAMIFLU (Roche's Oseltamivir) in China
4 Prices of Oseltamivir for Different Manufacturers in China, 2020-2021
4.1 Yichang HEC Changjiang Pharmaceutical Co., Ltd. (Kewei)
4.2 Shanghai Roche Pharmaceuticals Ltd. (TAMIFLU)
4.3 Roche Pharma (Schweiz) AG (TAMIFLU)
5 Prospect of Chinese Oseltamivir drug Market, 2021-2025
5.1 Influential Factors of Chinese Oseltamivir Market Development
5.1.1 The Impact of COVID-19 on Chinese Oseltamivir Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend
List of Charts
Chart Patent Information About Oseltamivir Registration in China
Chart Sales Value of Oseltamivir over the World
Chart Sales Value of Oseltamivir in China, 2016-2020
Chart Sales Value of Oseltamivir in China by Regions, 2016-2020
Chart Sales Volume of Oseltamivir in China, 2016-2020
Chart Sales Volume of Oseltamivir in China by Regions, 2016-2020
Chart Sales Value of Oseltamivir Granule in China, 2016-2020
Chart Sales Volume of Oseltamivir Granule in China, 2016-2020
Chart Sales Value of Oseltamivir Capsule in China, 2016-2020
Chart Sales Volume of Oseltamivir Capsule in China, 2016-2020
Chart Market Share by Sales Value of Top Oseltamivir Manufacturers in China, 2016-2020
Chart Sales Value and Volume of Kewei in China, 2016-2020
Chart Sales Value and Volume of TAMIFLU (Shanghai Roche’s Oseltamivir) in China, 2016-2020
Chart Sales Value and Volume of TAMIFLU (Roche’s Oseltamivir) in China, 2016-2020
Chart Referential Prices of Kewei in China, 2020-2021
Chart Referential Prices of TAMIFLU (Shanghai Roche’s Oseltamivir) in China, 2020-2021
Chart Referential Prices of TAMIFLU (Roche’s Oseltamivir) in China, 2020-2021
Chart Forecast on Sales Value of Oseltamivir in China, 2021-2025
Chart Forecast on Sales Volume of Oseltamivir in China, 2021-2025
